https://adisinsight.springer.com/drugsafety/803723975?error=cookies_not_supported&code=cdddefd6-e664-4726-805d-44a81cb774b6
Risk of EVUSHELD treatment failure due to antiviral resistance - AdisInsight
Prophylaxis or treatment with EVUSHELD (cilgavimab/tixagevimib) may fail due to antiviral resistance, warns Health Canada in association with AstraZeneca
due toriskevusheldtreatmentfailure
https://www.hpra.ie/find-a-medicine/for-human-use/authorised-medicines/details/38646
EVUSHELD 150 mg + 150 mg solution for injection
EVUSHELD 150 mg + 150 mg solution for injection
solution forevusheldmginjection